Showing results (281-290 of 434) with videos related to
Sort By:
Pageof 44
Clinical and Experimental Hepatology|November 4, 2020
Pemafibrate decreases markers of hepatic inflammation in patients with non-alcoholic fatty liver diseaseSatoshi Shinozaki, Toshiyuki Tahara, Alan Kawarai Lefor, et al.Clinical and Experimental Hepatology|November 4, 2020
Comparison of hepatic and splenic stiffness in chronic hepatitis C infection with and without schistosomal infection; correlation with hepatic histopathological changesAhmed Al Gohary, Amany Elyamany, Dina Abdalla, et al.Clinical and Experimental Hepatology|October 29, 2021
Overview of lenvatinib as a targeted therapy for advanced hepatocellular carcinomaObaid Rehman, Urooj Jaferi, Inderbir Padda, et al.Clinical and Experimental Hepatology|October 29, 2021
Direct antiviral agents for chronic hepatitis C virus infection improve health-related quality of life significantly in the long termMahmoud Atamla, Johad Khoury, Ihab Dabbah, et al.Clinical and Experimental Hepatology|October 29, 2021
Prevalence and prognostic value of cirrhotic cardiomyopathy as defined according to the proposed new classificationMaurizio Cesari, Anna Chiara Frigo, Salvatore Piano, et al.Clinical and Experimental Hepatology|October 29, 2021
Evaluation of different diagnostic modalities of minimal hepatic encephalopathy in cirrhotic patients: case-control studyTary Salman, Maha Elsabaawy, Mahmoud Omar, et al.Clinical and Experimental Hepatology|October 29, 2021
Hyaluronic acid as a potential marker for assessment of fibrosis regression after direct acting antiviral drugs in chronic hepatitis C patientsEman Rewisha, Tary Salman, Omkolsoum Alhaddad, et al.Clinical and Experimental Hepatology|October 25, 2017
New directions in hepatitis B therapy researchMarta Lewandowska, Anna PiekarskaClinical and Experimental Hepatology|October 25, 2017
The interplay between Th17 and T-regulatory responses as well as adipokines in the progression of non-alcoholic fatty liver diseaseMagdalena Świderska, Jerzy Jaroszewicz, Agnieszka Stawicka, et al.Clinical and Experimental Hepatology|September 1, 2017
The prevalence and severity of 25-(OH)-vitamin D insufficiency in HCV infected and in HBV infected patients: a prospective studyAleksandra Berkan-Kawińska, Ewa Koślińska-Berkan, Anna PiekarskaPageof 44